MedPath

The effect of some micronutrients supplementation in treatment of hypothyroidism

Phase 3
Conditions
Hypothyroidism.
Hypothyroidism, unspecified
E03.9
Registration Number
IRCT20200610047719N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
90
Inclusion Criteria

Hypothyroid patients who are candidates for levothyroxine
Age 19 to 65 years (both male and female)
Not to take vitamin D orally or by injection during the last 2-3 months
Willingness to participate in the study

Exclusion Criteria

History of various thyroid diseases
Smoking or taking addictive drugs or alcohol
Pregnancy and breastfeeding
Chronic renal failure, dialysis, diabetes, other autoimmune diseases and malignancies or taking certain medications
Critical condition in the last 3 months leading to hospitalization or cytokine use
Taking a variety of multivitamin mineral or antioxidant supplements as well as following a low-calorie diet 3 months before the start of the study
Participating in other clinical trials at the same time or recently

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thyroid stimulating hormone. Timepoint: Baseline and after intervention. Method of measurement: Blood test.
Secondary Outcome Measures
NameTimeMethod
Anti thyroid peroxidase. Timepoint: Baseline and after intervention. Method of measurement: Blood test.;Serum triglyceride. Timepoint: Baseline and after intervention. Method of measurement: Blood test.;Serum total cholesterol. Timepoint: Baseline and after intervention. Method of measurement: Blood test.;High density lipoprotein. Timepoint: Baseline and after intervention. Method of measurement: Blood test.;Low density lipoprotein. Timepoint: Baseline and after intervention. Method of measurement: Blood test.;Fasting blood sugar. Timepoint: Baseline and after intervention. Method of measurement: Blood test.;Serum fasting insulin. Timepoint: Baseline and after intervention. Method of measurement: Blood test.;Homeostatic model assessment for insulin resistance. Timepoint: Baseline and after intervention. Method of measurement: Calculation.
© Copyright 2025. All Rights Reserved by MedPath